🔴 Hims & Hers Health is trading 4.05% down with no confirmed company-specific catalyst

Hims & Hers Health is trading at €25.14, down 4.05%, with no confirmed company-specific catalyst reported for the October 22 decline.

• The October 21 testosterone-treatment launch has not been linked to the move.
• Broader markets sold off amid risk-off sentiment, geopolitical tensions and concerns about AI spending; these conditions provide context, not confirmed causation.
• Available information does not establish trading volume or a definitive reason for the decline.